Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Lancet
; 388(10058): 2355-2365, 2016 11 12.
Article
in En
| MEDLINE
| ID: mdl-27769562
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Organometallic Compounds
/
Drug Administration Schedule
/
Helicobacter pylori
/
Helicobacter Infections
/
Drug Therapy, Combination
/
Antacids
Type of study:
Clinical_trials
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Lancet
Year:
2016
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Reino Unido